Related Experiment Videos
Total cholesterol and mortality in patients with pre-existing coronary artery disease
Insights
High serum cholesterol is linked to cardiovascular mortality, but this study found no significant impact on long-term survival for patients with existing coronary artery disease. This suggests cholesterol levels may not be a primary predictor in this specific patient group.
Area of Science:
- Cardiology
- Clinical Research
- Epidemiology
Background:
- Serum cholesterol levels are positively correlated with cardiovascular mortality.
- The specific role of serum cholesterol in patients with established coronary artery disease (CAD) remains unclear.
Purpose of the Study:
- To investigate the association between total serum cholesterol levels and long-term survival in patients diagnosed with pre-existing coronary artery disease.
Main Methods:
- A cohort of 524 patients with coronary artery disease was stratified into four groups based on total serum cholesterol levels (≤200, 201-220, 221-240, >240 mg/dl).
- Actuarial survival analysis and hazard function analysis were performed over an 11-year follow-up period.
- Mortality rates were compared across the cholesterol groups, with adjustments for potential confounding factors.
Main Results:
- No statistically significant differences in overall mortality were observed between the four cholesterol groups over the 11-year follow-up (Logrank test, p > 0.1).
- Adjusted data analysis also revealed no significant differences in mortality rates (chi (2) = 4.73, p > 0.05).
- Hazard function analysis showed non-significant variations in death rates per thousand person-years across the groups.
Conclusions:
- Total serum cholesterol levels do not appear to influence long-term survival outcomes in individuals with pre-existing coronary artery disease.
- These findings suggest that cholesterol management strategies may need to be individualized for patients with established CAD.
Background:
A positive correlation exists between serum cholesterol levels and cardiovascular mortality. However, the role of serum cholesterol in persons with pre-existing coronary artery disease is not clear.
Methods:
A cohort of 524 patients with coronary artery disease was divided into four groups based on the total serum cholesterol values. Group I consisted of 68 patients with cholesterol levels of 200 mg/dl or less; Group II of 116 patients with cholesterol levels between 201 and 220 mg/dl; Group III of 187 patients with levels between 221 and 240 mg/dl and Group IV of 153 patients with cholesterol levels greater than 240 mg/dl.
Results:
Actuarial survival analysis over an 11-year follow up did not show any overall difference in mortality between these groups (Logrank test statistic = 1.89, p > 0.1). Analysis after adjustment of the data also showed that mortality rates were not different (chi (2) = 4.73, p > 0.05). Hazard function analysis indicated that death rates per thousand person years of follow up were 49.97 +/- 8.4 in Group I, 41.38 +/- 8.4 in Group II, 55.39 +/- 4.4 in Group III and 45.38 +/- 6.4 in Group IV. These were also not statistically significant. Comparison of mortality rates in patients with angina pectoris and past myocardial infarction also showed similar results.
Conclusion:
Total serum cholesterol levels do not influence long term survival in patients with pre-existing coronary artery disease.